ストックスクリーナーアプリを入手
2.31
54.48%
0.86
前日終値:
$1.45
開ける：
$1.55
24時間の取引高:
20.19M
Relative Volume:
1.40
時価総額：
$105.49M
収益：
$1.20M
当期純損益:
$-52.41M
株価収益率:
-2.5385
EPS:
-0.91
ネットキャッシュフロー:
$-31.25M
1週間 パフォーマンス:
+23.08%
1か月 パフォーマンス:
+348.18%
6か月 パフォーマンス:
+101.80%
1年 パフォーマンス:
-2.18%
1日の値動き範囲:
$1.535
$2.30
1週間の範囲:
$1.42
$2.30
52週間の値動き範囲:
$0.387
$3.87
Rani Therapeutics Holdings Inc Stock (RANI) Company Profile
名前
Rani Therapeutics Holdings Inc
セクター
電話
(408) 457-3700
住所
2051 RINGWOOD AVENUE, SAN JOSE
RANI を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RANI
Rani Therapeutics Holdings Inc
|
2.2399 | 141.43M | 1.20M | -52.41M | -31.25M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.74 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
649.74 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.60 | 58.93B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
806.26 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
187.71 | 41.29B | 398.11M | -1.03B | -868.57M | -5.7032 |
Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-08-02 | 開始されました | Oppenheimer | Outperform |
| 2024-06-14 | 開始されました | Maxim Group | Buy |
| 2024-06-13 | 開始されました | Rodman & Renshaw | Buy |
| 2023-04-17 | 再開されました | BTIG Research | Buy |
| 2022-10-11 | 開始されました | UBS | Buy |
| 2022-07-27 | 開始されました | H.C. Wainwright | Buy |
| 2022-06-13 | 開始されました | Wedbush | Outperform |
すべてを表示
Rani Therapeutics Holdings Inc (RANI) 最新ニュース
Can Rani Therapeutics Holdings Inc. stock maintain growth trajectoryJuly 2025 Market Mood & Low Risk Investment Opportunities - newser.com
Multi asset correlation models including Rani Therapeutics Holdings Inc.2025 Stock Rankings & Low Drawdown Momentum Ideas - newser.com
Technical analysis overview for Rani Therapeutics Holdings Inc. stock2025 Growth vs Value & Consistent Income Trade Recommendations - newser.com
Is Rani Therapeutics Holdings Inc. stock a buy for dividend growthIPO Watch & Safe Capital Preservation Plans - newser.com
Will Rani Therapeutics Holdings Inc. stock reach all time highs in 2025Short Setup & Real-Time Volume Analysis Alerts - newser.com
Institutional scanner results for Rani Therapeutics Holdings Inc.July 2025 Setups & Verified Momentum Stock Watchlist - newser.com
Rani Therapeutics to Present Preclinical Data on Oral Delivery of Semaglutide via the RaniPill® Capsule at ObesityWeek® 2025 - The Manila Times
Rani (Nasdaq: RANI) to present RT-116 bioequivalence data in dogs at ObesityWeek 2025 - Stock Titan
Short interest data insights for Rani Therapeutics Holdings Inc.Stop Loss & Intraday High Probability Setup Alerts - newser.com
Can momentum traders help lift Rani Therapeutics Holdings Inc.Earnings Performance Report & Weekly Sector Rotation Insights - newser.com
Rani Therapeutics Holdings (RANI) Price Target Increased by 20.00% to 10.71 - Nasdaq
Is Rani Therapeutics Holdings Inc. stock supported by innovation pipelineOptions Play & AI Powered Market Entry Strategies - newser.com
Rani Therapeutics (NASDAQ:RANI) Director Mir Imran Buys 2,083,334 Shares - MarketBeat
Rani Therapeutics Hits New 52-Week High of $3.87, Marking Major Milestone - Markets Mojo
Hedge Fund and Insider Trading News: Ray Dalio, Bill Ackman, Israel Englander, Ken Griffin, Michael Burry, Warren Buffett, ExodusPoint Capital, Rani Therapeutics Holdings Inc (RANI), Coca-Cola Co (KO), and More - Insider Monkey
Rani Therapeutics Holdings Insider Bought Shares Worth $1,260,417, According to a Recent SEC Filing - MarketScreener
Will Rani Therapeutics Holdings Inc. bounce back from current supportMarket Activity Report & Weekly Breakout Stock Alerts - newser.com
How to integrate Rani Therapeutics Holdings Inc. into portfolio analysis tools2025 Macro Impact & Daily Volume Surge Signals - newser.com
Rani Therapeutics director Imran Mir a buys $1.26 million in stock - Investing.com Philippines
Rani Therapeutics director Imran Mir a buys $1.26 million in stock By Investing.com - Investing.com South Africa
Rani Therapeutics Launches Phase 1 Study for Obesity Treatment RT-114 - TipRanks
Rani Therapeutics appoints new directors and closes private placement By Investing.com - Investing.com Nigeria
Rani Therapeutics appoints new directors and closes private placement - Investing.com
Rani Therapeutics Announces Board Changes - TradingView
Rani Therapeutics Holdings Inc (RANI) 財務データ
収益
当期純利益
現金流量
EPS
Rani Therapeutics Holdings Inc (RANI) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| South Cone Investments Limited | 10% Owner |
Oct 21 '25 |
Sale |
2.77 |
4,000,000 |
11,074,000 |
2,379,194 |
| South Cone Investments Limited | 10% Owner |
Oct 20 '25 |
Sale |
2.41 |
1,923,000 |
4,637,314 |
6,379,194 |
| McKinley Kate | Chief Business Officer |
Dec 13 '24 |
Buy |
1.67 |
17,960 |
29,993 |
17,960 |
| Imran Talat | Chief Executive Officer |
Dec 09 '24 |
Buy |
1.94 |
10,296 |
19,974 |
494,751 |
1.00%
0.94%
大文字化:
|
ボリューム (24 時間):